TotalMarketCap

Candel Therapeutics

CADLNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$615.592 M

$8.05 -11.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Candel Therapeutics (CADL) has a market capitalization of $615.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$38.2M

Loss-making

Shares outstanding

76,518,565

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #57Bambusa TherapeuticsBBTX$631.2M
  2. #584D Molecular TherapeuticsFDMT$621.8M
  3. #59Candel TherapeuticsCADL$615.6M
  4. #60DBV TechnologiesDBVT$614.9M
  5. #61Iambic TherapeuticsIAM$550.1M

What if Candel Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$369,019.91

Per share 45,869× higher

Bitcoin $1.53T

$19,967.02

Per share 2,482× higher

Apple $5.02T

$65,549.88

Per share 8,148× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Candel Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.